F. Clementi

561 total citations
21 papers, 458 citations indexed

About

F. Clementi is a scholar working on Molecular Biology, Neurology and Surgery. According to data from OpenAlex, F. Clementi has authored 21 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Neurology and 3 papers in Surgery. Recurrent topics in F. Clementi's work include Nicotinic Acetylcholine Receptors Study (6 papers), Myasthenia Gravis and Thymoma (5 papers) and Ion channel regulation and function (3 papers). F. Clementi is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (6 papers), Myasthenia Gravis and Thymoma (5 papers) and Ion channel regulation and function (3 papers). F. Clementi collaborates with scholars based in Italy. F. Clementi's co-authors include Cecilia Gotti, B Ceccarelli, S. Vailati, Loredana Riganti, Emanuele Sher, Jacopo Meldolesi, Francesca Conti, E. Chiesara, Nica Borgese and Guido Francesco Fumagalli and has published in prestigious journals such as Journal of Neuroscience, Neurology and Neuroscience.

In The Last Decade

F. Clementi

20 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Clementi Italy 11 321 149 64 54 33 21 458
Chung-Jiuan Jeng Taiwan 14 248 0.8× 101 0.7× 30 0.5× 25 0.5× 27 0.8× 18 397
L. Svennerholm Sweden 9 353 1.1× 132 0.9× 33 0.5× 75 1.4× 32 1.0× 17 619
Juan Fernando Padín Spain 15 276 0.9× 193 1.3× 51 0.8× 27 0.5× 26 0.8× 43 554
Anne Dumbrille-Ross Canada 14 348 1.1× 335 2.2× 52 0.8× 18 0.3× 23 0.7× 16 555
Katherine Fisher United States 12 194 0.6× 102 0.7× 55 0.9× 27 0.5× 16 0.5× 17 456
Helen Boyd Australia 12 240 0.7× 109 0.7× 36 0.6× 10 0.2× 10 0.3× 18 461
Robert A. Moyer United States 10 279 0.9× 263 1.8× 49 0.8× 7 0.1× 22 0.7× 20 540
Siret D. Jaanus United States 12 175 0.5× 108 0.7× 19 0.3× 14 0.3× 25 0.8× 28 407
Julie Cianfrogna United States 7 168 0.5× 108 0.7× 46 0.7× 14 0.3× 10 0.3× 7 463
Norell M. Hadzimichalis United States 7 126 0.4× 116 0.8× 25 0.4× 16 0.3× 19 0.6× 8 314

Countries citing papers authored by F. Clementi

Since Specialization
Citations

This map shows the geographic impact of F. Clementi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Clementi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Clementi more than expected).

Fields of papers citing papers by F. Clementi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Clementi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Clementi. The network helps show where F. Clementi may publish in the future.

Co-authorship network of co-authors of F. Clementi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Clementi. A scholar is included among the top collaborators of F. Clementi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Clementi. F. Clementi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clementi, F., Guido Francesco Fumagalli, & Cristiano Chiamulera. (2015). General and molecular pharmacology : principles of drug action. Medical Entomology and Zoology. 11 indexed citations
2.
Grazioso, Giovanni, et al.. (2013). Nicotine-Modulated Subunit Stoichiometry Affects Stability and Trafficking of  3 4 Nicotinic Receptor. Journal of Neuroscience. 33(30). 12316–12328. 50 indexed citations
3.
Donzelli, Alberto, Daniela Braida, Roberta Martucci, et al.. (2011). 11,2-bis-N-cytisinylethane (CC4), a new nicotinic partial agonist, blocks nicotine- and Δ-9-tetrahydrocannabinol-induced conditioned place preference in zebrafish. Neuroscience. 1 indexed citations
4.
Martuscelli, Eugenio, F. Clementi, Mark M. Gallagher, et al.. (2007). Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial. European Journal of Cardio-Thoracic Surgery. 33(1). 4–8. 12 indexed citations
5.
Gotti, Cecilia, Loredana Riganti, S. Vailati, & F. Clementi. (2006). Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery. Current Pharmaceutical Design. 12(4). 407–428. 144 indexed citations
6.
Vailati, S., Milena Moretti, Renato Longhi, et al.. (2003). Developmental Expression of Heteromeric Nicotinic Receptor Subtypes in Chick Retina. Molecular Pharmacology. 63(6). 1329–1337. 21 indexed citations
7.
Clementi, F., et al.. (1998). [C-reactive protein in pulmonary tuberculosis treated with pneumothorax].. PubMed. 14. 347–54.
8.
Clementi, F., Cristina Missale, F. Boroni, et al.. (1995). Opioid modulation of voltage-operated calcium channels, hormone release and cell proliferation in a small-cell lung carcinoma cell line. Pharmacological Research. 31. 183–183. 1 indexed citations
9.
Rossoni, Giuseppe, et al.. (1994). ω-Conotoxin GVIA binds to and blocks rat neuromuscular junction. Neuroscience Letters. 176(2). 185–188. 18 indexed citations
10.
Giombelli, Ermanno, et al.. (1987). Tethered cord syndrome in an adult: Clinical and neuroradiological features. Neurological Sciences. 8(2). 157–160. 1 indexed citations
11.
Clementi, F. & Emanuele Sher. (1985). Antibody induced internalization of acetylcholine nicotinic receptor: kinetics, mechanism and selectivity.. PubMed. 37. 220–8. 8 indexed citations
12.
Sher, Emanuele & F. Clementi. (1984). Effect of specific antibodies on acetylcholine receptor turnover. Neurology. 34(2). 208–208. 10 indexed citations
13.
Clementi, F., Emanuele Sher, & Annalaura Erroi. (1983). Acetylcholine receptor degradation: study of mechanism of action of inhibitory drugs.. PubMed. 29(2). 274–80. 11 indexed citations
14.
Fumagalli, Guido Francesco, et al.. (1981). Antibody‐induced degradation of acetylcholine receptor in myasthenia gravis. Neurology. 31(11). 1440–1440. 19 indexed citations
15.
Fumagalli, Guido Francesco, et al.. (1980). Myasthenia gravis: an example of receptor disease.. PubMed. 21. 473–88. 4 indexed citations
16.
Ceccarelli, B & F. Clementi. (1979). Neurotoxins, tools in neurobiology. Medical Entomology and Zoology. 80 indexed citations
17.
Clementi, F., et al.. (1970). SUBCELLULAR LOCALIZATION OF NEUROTRANSMITTERS AND RELEASING FACTORS IN THE RAT MEDIAN EMINENCE. Journal of Endocrinology. 48(2). 205–213. 26 indexed citations
18.
Chiesara, E., F. Clementi, Francesca Conti, & Jacopo Meldolesi. (1967). The induction of drug-metabolizing enzymes in rat liver during growth and regeneration. A biochemical and ultrastructural study.. PubMed. 16(2). 254–67. 32 indexed citations
19.
Meldolesi, Jacopo & F. Clementi. (1967). [The endoplasmic reticulum of the hepatic cell after the administration of drugs].. PubMed. 15(3). 215–28. 6 indexed citations
20.
Clementi, F.. (1965). Second International Symposium on Drugs Affecting Lipid Metabolism. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026